AfaSci, Inc., a San Francisco Bay Area biotech company committed to enhancing health care by conducting R&D in both Biotechnology and Therapeutics. Our bioengineering team has designed, produced and been marketing an in vivo drug screening platform, SmartCageTM. This system enables automated, and objective assessment of drug effects on rodent behavior and increases throughput of phenotyping of transgenic animals. Elevating our proprietary platform and well-established electrophysiological techniques, AfaSci’s scientists have been discovering IND drug candidates targeting ion channels and GPCR for the treatment of CNS disorders, especially neuropathic pain, epilepsy and Alzheimer’s disease.
View Top Employees from AFASCI, INC.Website | http://www.afasci.com |
Revenue | $11 million |
Employees | 9 (9 on RocketReach) |
Founded | 2003 |
Address | 522 Second Avenue, Redwood City, California 94063, US |
Phone | (650) 995-7320 |
Fax | (650) 692-6051 |
Technologies |
JavaScript,
HTML,
PHP
+7 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular AFASCI, INC. employee's phone or email?
The AFASCI, INC. annual revenue was $11 million in 2024.
Xinmin Xie is the President and Chief Executive Officer of AFASCI, INC..
9 people are employed at AFASCI, INC..
AFASCI, INC. is based in Redwood City, California.
The NAICS codes for AFASCI, INC. are [541714, 541, 54, 54171, 5417].
The SIC codes for AFASCI, INC. are [873, 87].